Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00259727 · ClinicalTrials.gov registry record
The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 80
- Enrollment target
NCT00259727: Completed study, sponsored by US Department of Veterans Affairs.
NCT00259727 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00259727 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2006-01 |
| Est. Completion | 2008-09 |
What the finished NCT00259727 record still lists
NCT00259727 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00259727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00259727 about?
NCT00259727 is a clinical study titled "The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism". The purpose of this study is to determine the mechanisms by which HIV protease inhibitors contribute to the development of diabetes in HIV-infected patients. The investigators propose that some HIV protease inhibitors impair insulin secretion and increase the production of glucose by the liver.
What is the current status of trial NCT00259727?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2006-01. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00259727?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia